Project 3: ACHIEVE- CHD
Launched by UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER · Jun 15, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The ACHIEVE-CHD trial is part of a larger project aimed at improving heart health and reducing health inequalities among Black and African American individuals living in Detroit and Cleveland. Specifically, this trial focuses on coronary heart disease (CHD), which is a condition that can lead to serious heart problems. The study will involve Community Health Workers (CHWs) who will provide support and education to help participants manage their health better. Participants will also receive training to ensure that the CHWs deliver effective care.
To be eligible for this study, participants must be between 40 and 75 years old, self-identify as Black or African American, and live in the Cleveland Metro Area. They should have at least two risk factors for heart disease, such as being overweight or having high blood pressure. Participants will need to complete a specific heart test and be willing to work with healthcare providers. The trial is currently recruiting participants and aims to improve heart health outcomes for those who join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. 40 to 75 years of age
- • 2. Self-identified as Black or African American
- • 3. Residence in the Cleveland Metro Area
- 4. Must have at least two of the following risk factors identified at a UH health fair screenings, with one risk factor being with SBP, A1c, or LDL:
- • 1. BMI≥30 mg/dL
- • 2. History of smoking
- • 3. Elevated blood pressure defined as SBP\>140 or DBP\>80 mmHg
- • 4. HbA1c≥5.7%
- • 5. LDL≥130
- • 5. Able to complete a coronary artery calcium score test (CAC)
- • 6. Willing and able to consent
- • 7. Willing to have a UH provider and UH care
- • 8. Currently insured for standard of care procedures
- Exclusion Criteria:
- • 1. Established documented cardiovascular disease (coronary artery disease, peripheral artery disease, myocardial infarction, stroke).
- • 2. Systolic blood pressure ≥ 180 mmHg or diastolic blood pressure ≥ 110 mmHg
- • 3. Lung disease requiring supplemental oxygen therapy
- • 4. Individuals receiving treatment for cancer related disease
- • 5. Pregnant or nursing mothers
About University Hospitals Cleveland Medical Center
University Hospitals Cleveland Medical Center is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with Case Western Reserve University, the center integrates cutting-edge medical education, comprehensive patient care, and pioneering clinical trials to enhance treatment options and improve patient outcomes. With a diverse range of specialized programs and a robust infrastructure for research, University Hospitals Cleveland Medical Center plays a vital role in translating scientific discoveries into effective therapies, ensuring access to the latest advancements in medicine for patients and communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Patients applied
Trial Officials
Sanjay Rajagopalan, MD
Principal Investigator
University Hospitals Cleveland Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported